Home > M&A deals 2018 > Recipharm AB acquires Sanofi SA - Inhalation Contract Manufacturing Business
Divestiture · Medical Products · October 2018

Recipharm AB acquires Sanofi SA - Inhalation Contract Manufacturing Business

On October 1, 2018, Recipharm AB acquired Sanofi SA - Inhalation Contract Manufacturing Business, a medical products company in France, from Sanofi SA.

Deal at a glance

AnnouncedOctober 1, 2018 TypeDivestiture TargetSanofi SA - Inhalation Contract Manufacturing Business Buyer Recipharm AB Seller Sanofi SA SectorMedical Products LocationFrance ValueNot disclosed

Target company

Sanofi SA - Inhalation Contract Manufacturing Business
France
Medical Productssector
-founded
Activestatus
View the company profile →

Buyer

Recipharm AB
Company · 18 deals on record
  • 1st transaction in medical products
  • 2nd transaction in France
18deals, all time
1in this sector
2022latest

Seller

Sanofi SA
Company · 35 deals on record
35investments
5in this sector
14exits

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Arranta BioSame lead buyer · Feb 2022
VibalogicsSame lead buyer · Feb 2022
Aquilab SASSame sector and country · Apr 2022
Impeto Medical SASSame sector and country · Jan 2022

Questions about this deal

Who acquired Sanofi SA - Inhalation Contract Manufacturing Business?Recipharm AB acquired Sanofi SA - Inhalation Contract Manufacturing Business on October 1, 2018.

Who sold Sanofi SA - Inhalation Contract Manufacturing Business?Sanofi SA was the seller.

What type of deal was it?It was a divestiture in the medical products sector in 2018.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).